NeXstar Pharmaceuticals Incorporated

NeXstar Pharmaceuticals, Inc., is an integrated biopharmaceutical company engaged in the discovery, development, manufacture and marketing of proprietary pharmaceutical products to treat life-threatening and other serious oncological,hematological and infectious diseases. NeXstar Pharmaceuticals employs a broad range of proprietary technologies in the discovery and formulation of pharmaceutical products, including the Company's liposome drug delivery technology; a powerful combinatorial chemistry technology known as the SELEX process that rapidly identifies novel oligonucleotide compounds with potential therapeutic and diagnostic benefits; and Evolutionary Chemistry, designed to rapidly discover small organic molecules to serve as orally available drugs. The Company's technologies have produced two approved drugs and several drug candidates that are in clinical or preclinical development and have provided the basis for a significant pipeline of drug development candidates.

Contact Details: 2860 Wilderness Place Boulder CO 80301 United States of America Tel: 303 444 5893 Fax: 303 444 0672 Email: WWW: www.nexstar.com/

Loading...

Recent Publications by NeXstar Pharmaceuticals Incorporated:
Theoretical principles of in vitro selection using combinatorial nucleic acid libraries. A new paradigm for drug discovery and biological research has developed...	9th May, 2008	NeXstar Pharmaceuticals, Boulder, Colorado, USA.	Curr Protoc Nucleic Acid Chem. 2000 Feb;Chapter 9:Unit 9.1. DOI Direct Link
Tumor targeting by an aptamer. Aptamers are small oligonucleotides that are selected to bind tightly and...	20th June, 2006	NeXstar Pharmaceuticals,	J Nucl Med. 2006 Apr;47(4):668-78.
Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo. Therapeutic and diagnostic applications have been envisioned for aptamers,...	12th August, 2000	NeXstar Pharmaceuticals, Inc., Boulder, CO 80301, USA.	Antisense Nucleic Acid Drug Dev. 2000 Apr;10(2):63-75.
The use of aptamers in large arrays for molecular diagnostics. BACKGROUND: Aptamers are single-stranded oligonucleotides derived from an...	25th March, 2000	NeXstar Pharmaceuticals, Inc, Boulder, Colorado 80301, USA.	Mol Diagn. 1999 Dec;4(4):381-8. DOI Direct Link

BioNews Results for NeXstar Pharmaceuticals Incorporated:
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer	FinanzNachrichten.de:  Nov 16 2009 12:34AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Kansas City Business Journal:  Nov 16 2009 3:25AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	South Florida Business Journal:  Nov 16 2009 3:23AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Washington Business Journal:  Nov 16 2009 1:25AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	St Louis Business Journal:  Nov 16 2009 12:45AM Matching: pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more NeXstar Pharmaceuticals Incorporated news.

NeXstar Pharmaceuticals Incorporated Clinical Trials:
A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

NeXstar Pharmaceuticals Incorporated Patents:
US Patent No.	Title
5846713	High affinity HKGF nucleic acid ligands and inhibitors
5945527	Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
5958449	Antibiotic formulation and use for bacterial infections
5958691	High affinity nucleic acid ligands containing modified nucleotides
5959100	Pyrimidine nucleosides as therapeutic and diagnostic agents
→View more NeXstar Pharmaceuticals Incorporated patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 17 individuals from NeXstar Pharmaceuticals Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 994 times since April 2007, the link to the organisation's website has been followed 236 times

Recent Search Terms used to find this page: Evolutionary Chemistry and NeXstar Pharmaceuticals Inc. | NeXstar aptamer | Nexstar Pharmaceuticals Ltd | NeXstar Pharmaceuticals | nexstar pharmaceuticals 2009 | 303-444-5893 | nexstar pharmaceuticals contact | Nexstar Pharmaceuticals Ltd product | nexstar pharma | nexstar pharma | .

Search for more companies in Boulder

Search for more companies in CO

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for NeXstar Pharmaceuticals Incorporated